InvestigationalLong-acting amylin analogWeight loss
Cagrilintide
Cagrilintide is Novo Nordisk's investigational long-acting amylin analog, studied alone and with semaglutide (CagriSema).
What is Cagrilintide?
Cagrilintide is Novo Nordisk's investigational long-acting amylin analog, studied alone and with semaglutide (CagriSema). Cagrilintide is an investigational compound: it has been studied in clinical trials but has no FDA approval.
Key takeaways
- Cagrilintide is an investigational compound: it has been studied in clinical trials but has no FDA approval.
- PubMed indexes 103 papers on Cagrilintide (15 tagged as clinical trials) as of October 19, 2026.
- ClinicalTrials.gov lists 44 registered studies using Cagrilintide.
- 27 vendors in our directory listed Cagrilintide in their public catalog on October 19, 2026.
Regulatory & access status
Cagrilintide is an investigational compound: it has been studied in clinical trials but has no FDA approval.
Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.
How much research exists on Cagrilintide?
PubMed indexes 103 papers mentioning Cagrilintide in the title or abstract, 103 of them from the last five years and 15 tagged as clinical trials (search run October 19, 2026; repeat the search).
Most relevant recent papers
- Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis. — BMJ, 2024 · review
- Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. — N Engl J Med, 2025 · clinical trial
- Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes. — N Engl J Med, 2025 · clinical trial
- Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. — Lancet, 2021 · clinical trial
- Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity. — Cardiol Rev, 2024
- Weight management treatment in obesity. — Med Clin (Barc), 2025 · review
Registered clinical studies
ClinicalTrials.gov lists 44 studies with Cagrilintide as an intervention (see all). Most recent:
- Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes — NCT06403761 · Phase 1 · completed · started 2024-05-06
- A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet — NCT07184086 · Phase 1 · active not recruiting · started 2025-09-26
- A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor — NCT06065540 · Phase 3 · completed · started 2023-09-27
- Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide — NCT07220759 · Phase 3 · active not recruiting · started 2025-11-05
- A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight — NCT06388187 · Phase 3 · completed · started 2024-06-24
What the evidence does not show
- Paper counts measure research attention, not whether Cagrilintide works or is safe.
- No FDA review of any "research use only" product's identity, purity, sterility or dose.
Blends that contain Cagrilintide
Research suppliers that list Cagrilintide
27 vendors in our directory listed a product matching Cagrilintide in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.
- Amino Amigos
- Backroad Aminos
- Biocollex Research
- BioGenix Peptides
- BioLongevity Labs
- Bulk Peptide Supply
- Dynamic Peptide
- Eros Peptides
- Evolve BioPep
- Extreme Peptides
- Liberty Peptides
- Licensed Peptides
- Modern Aminos
- NuScience Peptides
- Paramount Peptides
- Peptide Crafters
- Peptide Partners
- Plum Labs Research
- Polaris Peptides
- Prime Lab Peptides
- ProtideHealth
- Pure Lab Peptides
- Ramp Peptides
- Royal Peptides
- San Diego Peptides
- Sunrise BioResearch
- Xcel Peptides
Prices per mg, where we could verify them, are on our price comparison.
Cagrilintide reconstitution math
Lab arithmetic only, not dosing guidance: vial-by-vial concentration tables are on Cagrilintide 10 mg vial math.
Cagrilintide FAQ
Is Cagrilintide FDA-approved?
Cagrilintide is an investigational compound: it has been studied in clinical trials but has no FDA approval.
Is Cagrilintide safe?
Safety data come from the published studies listed on this page; read them in full. Products sold as "research use only" have no FDA review of their purity, sterility or dose.
How much research is there on Cagrilintide?
PubMed indexes 103 papers on Cagrilintide (15 tagged as clinical trials) as of October 19, 2026.
Who sells Cagrilintide?
Amino Amigos, Backroad Aminos, Biocollex Research, BioGenix Peptides, BioLongevity Labs, Bulk Peptide Supply and 21 more listed it on their public catalogs when we checked; a listing is not an endorsement.
Related compounds
SemaglutideLiraglutideTirzepatideAICARL-carnitineMOTS-cRetatrutideTesamorelinAll weight loss & glp-1